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Heme protein.mediated renal injury: A protective role for 21.amino-
steroids in vitro and in vivo. 21-aminosteroids ("lazaroids") have recently
excited much interest by virtue of their ability to inhibit lipid peroxidation
in vitro and to protect against neural injury in vivo. We tested the effect of
these compounds in models of heme protein-mediated renal injury in vitro
and in vivo. We devised an in vitro model of heme protein-induced toxicity
in which renal epithelial cells were exposed to heme proteins for one hour,
after which they were subjected to glutathione depletion by 1-chloro-2,4-
dinitrobenzene (CDNB). This model was associated with more than a
threefold increase in lipid peroxidation (as measured by thiobarbituric
acid reactive substances, TBARS) and a marked reduction in cellular
glutathione content. In this model, 21-aminosteroids virtually prevented
cytotoxicity as measured by the 51-chromium release assay, and signifi-
cantly reduced TBARS in a dose-dependent manner. Catalase was
partially protective in this model, thereby indicating hydrogen peroxide-
dependent toxicity. While pursuing mechanisms accounting for enhanced
cellular generation of hydrogen peroxide, we uncovered the first direct
evidence that the heme prosthetic group per se directly stimulates cellular
generation of hydrogen peroxide; complementing these findings is the
remarkable efficacy of 21-aminosteroids in protecting against cytotoxicity
induced by hydrogen peroxide. We also tested the capacity of 21-ami-
nosteroids to protect against heme protein-mediated renal injury in vivo.
Prior administration of 21-aminosteroids attenuated reductions in GFR
and renal blood flow rates following the systemic infusion of methemo-
globin in normal rats. 21-aminosteroids also attenuated renal injury
observed over three successive days in the glycerol model of heme
protein-mediated injury when this model was induced at a higher dose of
glycerol (8 mI/kg body wt) but not at a lower dose (5 ml/kg body wt). We
conclude that 21-aminosteroids protect against heme protein-mediated
renal injury in Vitro and in vivo. We suggest that these compounds are
potentially useful in such clinical conditions as rhabdomyolysis, intravas-
cular hemolysis and renal injury associated with hemoglobin-based red
blood cell substitutes.
Ubiquitously disposed within intracellular compartments and
intimately involved in a veritable host of cellular processes, heme
proteins are indispensable to cellular vitality [1, 2]. Yet, in certain
settings, heme proteins are undeniably toxic [3—7], and high up on
that rank of organs prone to such toxicity, haplessly, stands the
kidney. The proclivity with which such pernicious effects of heme
proteins are perpetrated upon the kidney is underscored by the
early and marked decline in renal function in such clinical syndromes
as rhabdomyolysis and intravascular hemolysis wherein myoglobin
and hemoglobin are discharged into the extracellular space [7, 8].
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Additionally, the occurrence of renal injury following the adminis-
tration of hemoglobin is one of the major impediments in the
development of a safe, hemoglobin-based, red blood cell substitute
[9, 10], a therapeutic objective motivating considerable research
effort [11], and one made all the more pressing with the continually
rising specter of AIDS as a complication of red blood cell transfu-
sions [12].
The development of safe and effective therapies directed
against heme protein-mediated renal toxicity would be aided by
understanding the mechanisms underlying such injury. In this
latter regard there is a general consensus that renal damage
induced by heme proteins represents the confluence and inter-
mingling of three major pathophysiologic pathways, namely, renal
vasoconstriction, direct cellular toxicity and the effects of heme
protein-mediated nephron cast formation [3—7, 13]. Opinions,
however, often diverge when assigning relative importance to
specific biochemical events [3—5, 14]. For example, there are
several lines of evidence supporting the role of oxidative stress in
general, and lipid peroxidation in particular, in the pathogenesis
of heme protein-mediated renal injury [3, 4, 15]: in the kidney,
lipid peroxidation is increased [3, 4] and glutathione is diminished
[15] in the glycerol model of acute renal failure in the rat, a model
in which hemoglobin and myoglobin are critical instigators of
renal damage; chelators of iron are protective in this model as are
scavengers of the hydroxyl radical [3, 4] and reduced glutathione
[15]; generation of hydrogen peroxide is increased in the glycerol
model [16] and toxicity induced by hydrogen peroxide in vitro is
exacerbated by myoglobin [17]. However, providing counterpoise
to these findings are meticulous and intriguing findings derived
from studies in vitro that call attention to the dissociation of lipid
peroxidation from iron-mediated cytotoxicity, the failure of myo-
globin to exert tissue toxicity to proximal tubular preparations,
and indeed, the capacity of myoglobin to protect against iron-
mediated renal injury [14].
The recent availability of 21-aminosteroids ("lazaroids") pro-
vides the opportunity of probing the involvement of lipid peroxi-
dation in heme protein-mediated injury as well as the prospect of
a novel therapeutic approach in the management of these disor-
ders. Intercalated into lipid bilayers, these lipophilic compounds
potently inhibit oxidant-induced lipid peroxidation [18, 19]. Inhi-
bition of lipid peroxidation accrues from several actions of these
compounds including their capacity to (i) scavenge peroxyl radi-
cals and other radicals capable of propagating a free radical chain
reaction, (ii) compete with aipha-tocopherol for reactive oxygen
species and thus attenuate the consumption of vitamin E that
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would otherwise occur, and (iii) impede, via a membrane-stabi-
lizing action, the mobility of reactive species in lipid domains, and
thus the propagation of free radical chain reactions [18, 19].
Several recent studies have emphasized the cytoprotective effects
of 21-aminosteroids in models of ischemic and traumatic injury to
neural tissue, a tissue enriched in unsaturated lipid and thus
vulnerable to peroxidative damage [19, 20]. Indeed, the efficacy of
these compounds are under examination in phase III clinical trials
in patients with subarachnoid hemorrhage, ischemic stroke and
head injury.
We thus undertook a combined in vitro and in vivo approach
examining the efficacy of these compounds in heme-mediated
renal injury, and in the course of these studies on the pathogenesis
of heme-mediated renal toxicity, we uncovered new insights into
the pathogenesis of heme protein-mediated renal injury.
Methods
Effect of heme-proteins on renal function in vivo
We performed renal clearance studies of both kidneys in rats
anesthetized with 5-sec-butyl-5-ethyl-2-thiobarbituric acid (mac-
tin, 100 mg/kg body wt, given i.p.) as described [21]. Glomerular
filtration rate (GFR) and renal plasma flow rates were determined
by the clearances of inulin and para-aminohippurate, respectively.
Approximately 1.5 hours prior to the administration of methemo-
globin or vehicle, a solution of U74389G (3 mg/Kg, Upjohn
Company, Kalamazoo, USA) was administered as an intravenous
bolus over several minutes; U74389G was dissolved at a concen-
tration of 1.5 mg/nil in citrate buffer provided by the Upjohn
Company. Approximately 1.5 hours after the administration of
U74389G, pyrogen-free methemoglobin, at a dose of 30 mg/100 g
body weight, was administered intravenously over three to four
minutes, and four consecutive clearance periods were conducted,
each a 1/2 hour in duration.
The glycerol model of heme protein-mediated injury
We examined this model, induced as previously described [21,
22], at two dosages of hypertonic glycerol, 5 ml/kg and 8 ml/kg
body weight. One hour prior to the intramuscular injection, a
solution of U74389G (3 mg/kg) was administered as a bolus by tail
vein over 15 to 20 seconds; U74389G was dissolved in citrate
buffer at a concentration of 1.5 mg/ml. Three additional doses of
U74389G were administered by tail vein injections at 2.5, 5.0 and
7 hours after the first dose. Daily serum creatinine determinations
were performed.
Heme protein cytotoxicily in vitro
Cytotoxicity was quantitated by the method of 51-chromium
(51Cr) release [23} following exposure of the cell monolayer to
methemoglobin in the presence or absence of CDNB (1-chloro-
2,4-dinitrobenzene) [24, 25]. LLC-PK1 cells were radiolabeled
overnight at 37°C by incubating each well with 5.0 tCi sodium
[5Cr] chromate (Amersham Corp., Arlington Heights, IL, USA)
in DMEM containing 10% fetal calf serum. The following morn-
ing cell monlayers were washed twice with HBSS and exposed to
human methemoglobin (20 M) in HBSS for one hour. In certain
studies, myoglobin (20 /LM and 80 LM) and porcine hemoglobin
(20 /.LM) (Sigma, St. Loius, MO, USA; 75% methemoglobin) were
employed instead of human methemoglobin. The heme protein-
containing solution was decanted and some wells were exposed to
CDNB (50 M) for 3.5 hours. CDNB was initially dissolved in
ethanol and then diluted in HBSS; the final concentration of
ethanol was 0.5%, and wells not treated with CDNB were exposed
to 0.5% ethanol.
To examine the effects of 21-aminosteroids on heme protein-
mediated cytotoxicity, we loaded LLC-PK1 cells overnight with
21-aminosteroid, U74389G (40 SM), simultaneously with the
loading of chromium. A total of 14.5 mg of U74389G was
dissolved in 0.5 ml dimethylsulfoxide, diluted to 4 m in HBSS
and quickly diluted to the final concentration of 40 jLM in DMEM.
Control cells were exposed to DMEM containing an identical
concentration of DMSO (0.1%). Following overnight incubation,
the cellular monlayer was washed twice with HBSS and exposed to
the conditions described above.
We point out that we employed concentrations of heme pro-
teins consistent with urinary concentrations detected in patients
with heme protein-triggered renal diseases; in rhabdomyolysis,
urinary concentrations of myoglobin may reach as high as 1200 j.LM
[26].
Lipid peroxidation assay
LLC-PK1 -associated lipid peroxidation was determined by mea-
suring the content of thiobarbituric acid reactive substances
(TBARS) [27]. It should be pointed out that while widely em-
ployed to measure lipid peroxidation, TBARS may originate from
other cellular sources besides lipid oxidation. Eight hundred
milliliters of thiobarbituric acid reagent (225 mg 2-thiobarbituric
acid, 1.19 ml of N HC1, 9 ml of 100% trichloracetic acid and
distilled water to a final volume of 30 ml) was added to suspension
of cells (400 !tl) in the presence of deferoxamine (1 m final
concentration). After heating at 100°C for 15 minutes, thiobarbi-
tune acid reactive substances was measured spectrophotometri-
cally at 532 nm using an extinction coefficient of 1.56 X 10 M
— 1/cm
—1, and the results expressed as pmoles per mg protein,
the latter measured on nonfractionated cellular protein homoge-
nate.
Measurement of total cellular thiol content
LLC-PK1 cells were grown to confluency on 10 cm petri plates.
Cells were washed twice with HBSS and then incubated with
methemoglobin (20 M) in HBSS or HBSS alone for one hour at
37°C. The overlying media was removed and the cell monolayers
were exposed to CDNB (50 LM) in HBSS or HBSS alone for an
additional 3.5 hours. The media was then replaced by 1 ml HBSS,
the cells scraped with a rubber policeman, transferred to a 1.5 ml
Eppendorf tube and centrifuged for 10 minutes at 400 g. Deter-
mination of cellular thiols was performed as previously described
[28].
Preparation of hemoglobin
Purified pyrogen-free hemoglobin was prepared from fresh
blood drawn from healthy volunteers and subjected to ion-
exchange chromatography on DEAE-Sepharose CL-6B column
(Pharmacia, Piscataway, NJ, USA) [29J. Eluates were dialyzed
and concentrated by Amicon ultrafiltration; hemoglobin was
assessed for purity using isoelectric focusing. All preparative steps
were carried out at 4°C. For short-term storage at —70°C,
hemoglobin was added dropwise to liquid nitrogen or used
immediately. Pyrogen-free methemoglobin was prepared by incu-
bation of hemoglobin with K3Fe(CN)6 in 1.5-fold excess over
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heme after which the methemoglobin was dialyzed [29]. Ferrohe-
moglobin, methemoglobin and hemichrome concentrations were
monitored by the measurement of the absorbances at 560, 577 and
630 nm as described by Winterbourn [30].
Detection of hydrogen peroxide generated by cells exposed to heme
Interactive laser cytometly. To quantitate the amount of hydro-
gen peroxide generated in cells exposed to heme, we employed
the probe, 2,7-dichlorofluorescin diacetate (Molecular Probes,
Eugene, OR, USA) and ACAS 570 Interactive Laser Cytometer
(Meridian Instruments Inc., Okemos, MI, USA) as described
previously [31]. Cell monolayers were first loaded with 2,7-
dichlorofluorescin diacetate and then exposed to heme in HBSS
at a concentration of 10 and 50 /LM for 2.5 hours; control cells
were exposed to HBSS alone. To calibrate cellular fluorescence,
we scanned confluent monolayers of LLC-PK1 cells exposed to
increasing concentrations of hydrogen peroxide, 50, 100 and 500
j.LM.
Aminotriazole-dependent inhibition of catalase. Cellular produc-
tion of hydrogen peroxide was also measured using the method of
aminotriazole-dependent inhibition of catalase [16, 31]. Confluent
monolayers in 10 cm petri plates were washed with 10 ml HBSS
and then incubated for 2 hours 20 minutes at 37°C in the presence
of 50 .LM heme in HBSS or HBSS alone. To half the dishes in each
group, aminotriazole was added at a concentration of 20 mM, and
all the cells incubated for an additional 10 minutes. The media
was decanted and cells washed with HBSS. Potassium phosphate
buffer (50 mrvi, pH 7.4) was then added, the cells scraped with a
rubber policeman and transferred to 1.5 ml Eppendorf tubes. The
tubes were repeatedly frozen and thawed and then sonicated for
60 seconds. The residual catalase activity was measured by an
enzymatic assay based on the rate of degradation of hydrogen
peroxide and expressed as absolute catalase activity and % control
values.
Extraction of RNA and Northern blot hybridization
LLC-PKI cells were loaded overnight with DMEM containing
U74389G (40 fLM) or DMEM containing 0.1% DMSO. Following
overnight incubation, the monolayers were washed with HBSS
and exposed to methemoglobin dissolved in HBSS (20 .tM) or
HBSS alone for one hour. The media was then decanted and
CDNB (50 jrM), dissolved as described above, or vehicle, was
added to petri plates. After one hour incubation at 37°C, the
media was decanted and DMEM was added for an additional
three hour incubation. RNA was extracted by the method of
Chomczynski and Sacchi [32] while northern blot hydridization
was performed as described by Rosenberg, Chmielewski and
Hostetter [33] using a heme oxygenase eDNA (supplied by Dr.
Rex Tyrrell, Epalinges, Switzerland).
Statistics
Data are expressed as means standard error of the means.
One-way ANOVA was employed for comparisons involving more
than two groups and the Student-Newman-Keuls test then ap-
plied. For sequential comparisons of two groups, two-way
ANOVA was employed. For single comparisons involving two
groups, the unpaired Student's t-test was used. For single com-
parisons involving two groups with nonparametric data, the
Mann-Whitney test was applied. Comparisons are considered
significant for P < 0.05.
Time, minutes
Fig. 1. Effect of prior treatment with 21-aminosteroids on reduction in GFR
following the infusion of heme proteins. Rats were pretreated with
U74389G (3 mg/kg body wt i.V.) or vehicle 1.5 hours prior to the
administration of methemoglobin, 30 mg/I 00 body weight, iv. Symbols are:
(E) control, N = 11; () MHgb + vehicle, N = 7; (•) MHgb + 21-AS,
N = 7. Four sequential clearance studies for the determination of GFR
were undertaken. Results (expressed as means 5EM) were analyzed by
one-way ANOVA and the Student-Newman-Keuls test. * P < 0.05 vs
control; t P < 0.05 vs. MHgb + 21-AS.
Results
Studies in vivo
21-aminosteroids protect against impairment in renal hemody-
namics induced by heme proteins. In preliminary studies, we
established that methemoglobin, 30 mg/100 g body weight, acutely
reduces renal blood flow rates and GFR, findings that are akin to
renal hemodynamic changes in an in vivo model of heme protein-
mediated cytotoxicity, the glycerol model. Indeed, plasma concen-
trations of heme two hours following the intravenous administra-
tion of hemoglobin, 30 mg/100 g body weight, are within the range
observed two hours after the induction of the glycerol model of
acute renal failure. We thus employed this intravenous dose of
hemoglobin in studies of acute renal hemodynamic alterations
induced by heme proteins.
The effects of prior administration of 21-aminosteroids on the
renal hemodynamic effects of methemoglobin are shown in Fig-
ures 1 and 2. A prompt decrement in GFR occurred within the
first clearance period (0 to 30 minutes) following the administra-
tion of heme proteins, and this persisted for the remaining three
clearance periods (Fig. 1). Prior administration of 21-aminoster-
oids attenuated the decrement in GFR induced by methemoglo-
bin leading to significantly higher GFR's in rats so treated in each
of the four periods (Fig. 1): following the administration of
methemoglobin, GFR in 21-aminosteroid-treated rats was in-
creased by 30, 68, 68 and 36% in periods ito 4, respectively, when
compared to vehicle-treated rats subjected to methemoglobin.
The data depicted for controls represent the means for all normal
rats not infused with methemoglobin, and includes rats treated
with either 21-aminosteroids (N = 6) or the vehicle for 21-
aminosteroids (N = 5). The mean values for either of these groups
were not significantly different for any of the clearance periods for
either GFR or renal blood flow rates.
21-aminosteroids also protected against the fall in renal blood
flow rates induced by heme proteins (Fig. 2). Indeed, renal blood
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Time, minutes
Fig. 2. Effect of prior treatment with 21-aminosteroids on reduction in renal
blood flow rates induced by heme proteins. Symbols are: (E) control, N =
11; () MHgb + vehicle, N = 6; (•) MHgb + 21-AS, N = 6. Rats were
pretreated with U74389G (3 mg/kg body wt i.v.) or vehicle 1.5 hour prior
to the administration of methemoglobin, 30 mg/l00 body wt, i.v. Four
sequential clearance studies for the determination of renal blood flow
rates were undertaken. Results (expressed as means SEM) were analyzed
by one-way ANOVA and the Student-Newman-Keuls test. * P < 0.05 vs.
control; P < 0.05 vs. MHgb + 21-AS.
flow rates in 21 -aminosteroid-treated rats subjected to heme
protein infusion were not significantly different from normal rats
not subjected to heme protein infusion in periods 1 and 2 (Fig. 2).
Thus 21-aminosteroids protect against the fall in renal blood flow
rates as well as in GFR in rats treated with heme proteins.
The administration of methemoglobin induced a prompt in-
crease in mean arterial pressure and such increments were not
affected by 21-aminosteroids. Mean arterial pressures (MAP)
significantly rose within five minutes of administration of methe-
moglobin and vehicle (basal MAP vs. MAP after 5 mm: 118 4
vs. 127 5 mm Hg, P < 0.005) and following the administration
of methemoglobin and 21-aministeroids (basal MAP vs. MAP
after 5 mm: 124 5 vs. 136 5 mm Hg, P < 0.005), representing
increments of 9 2 and 12 3 mm Hg, respectively. Neither the
absolute mean arterial pressures nor the increment in mean
arterial pressures were different between methemoglobin-treated
rats treated with either 21-aminosteroids or vehicle. By 25 to 30
minutes after the administration of methemoglobin, mean arterial
pressures had regained basal values in both groups. In control rats
treated with vehicle or 21 -aminosteroids mean arterial pressure
did not increase. Thus methemogobin induced a significant rise in
systemic arterial pressure that was not influenced by administra-
tion of 21-aminosteroids.
Compared to normal rats, calculated renal vascular resistances
were significantly increased in vehicle-treated rats subjected to
heme protein infusion, but were not significantly increased in rats
pretreated with 21-aminosteroids and subjected to heme protein
infusion. Such resistances in the first period were: Control, 8.7
0.5 vs. methemoglobin 18.0 3.0 versus methemoglobin +
21-aminosteroids, 10.1 1.3 mm Hg min/ml, respectively (P <
0.05). Thus 21-aminosteroids attenuate the augmentation in renal
vascular resistances that account for the fall in renal blood flow
rates in rats infused with heme proteins.
21-aminosteroids protect against renal impairment in the glycerol
model of acute renal failure at a high dose of hypertonic glycerol (8
0 1 2 3
Days
Fig. 3. Effect of prior treatment with 21-aminosteroids on impairment in
renal jhnction in the glycerol model (Gly, 8 mI/kg body wt). Symbols are: (D)
Gly, N = 12; () + 21-AS, N = 12. Rats were pretreated with U74389G
(3 mg/kg body wt iv.) or vehicle 1 hour prior to the administration of
hypertonic glycerol and the same dose of U74389G was administered
intravenously 2.5, 5 and 7 hours after the first dose. Daily serum creatinine
determinations were performed. Results (expressed as means SEM) were
analyzed by two-way ANOVA. Abbreviations are: Gly, glycerol model at
a dose of 8 mI/kg body wt; 21-AS, 21-aminosteroids, U74389G. * P < 0.05
vs. Gly.
mi/kg body wt) but not at a low dose (5 mI/kg body wt). Daily
measurements of serum creatinine to assess the effect of 21-
aminosteroids in the glycerol model of acute renal failure were
utilized. As shown in Figure 3, mean serum creatinine values were
lower on three sequential days in rats treated with 21-aminoste-
roids and subjected to glycerol-induced acute renal failure (50%
glycerol, 8 ml/kg body wt) thus indicating a protective effect of this
agent in this model of renal injury. However, using a less severe
form of renal injury in this model (50% glycerol, 5 ml/kg body wt),
21-aminosteroids failed to evince any protective effect in that the
mean serum creatinine in 21-aminosteroid-treated or vehicle-
treated rats subjected to glycerol at this dose were comparable on
day 1 (0.89 0.14 vs. 0.84 0.05 mg/dl, P = NS, N = 7 in each
group) and day 2 (0.59 0.07 vs. 0.56 0.03 mg/dl, P NS, N
7 in each group) following the administration of glycerol. Thus
21-aminosteroids protect against renal impairment when injury is
induced at the higher dose but not at the lower dose of hypertonic
glycerol.
Studies in vitro
21-aminosteroids protect against cytotoxicity induced by heme-
proteins in vitro. We first devised a model of heme protein-induced
cytotoxicity in vitro that simulates, at least in part, conditions that
occur in in vivo settings. In assorted pathologic diseases wherein
renal tubular epithelial cells are exposed to large amounts of
heme proteins, renal tubular epithelial cells are first conditioned
by ischemia, the latter provoked by the vasoconstrictive response
of heme proteins [7]. Ischemia exerts a multiplicity of damaging
actions including the cellular consumption of glutathione [34].
Diminution in renal content of glutathione occurs in the glycerol
model of heme protein kidney injury, and such decrement in
glutathione levels is a determinant of heme mediated toxicity [15].
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Fig. 4. TBARS in LLC-PK1 cells exposed to media alone (Control) or media
containing methemoglobin (20 jzvi) (MHgb), CDNB (50 psi) (CDNB),
CDNB (50 p.si) and methemoglobin (20 psi) (CDNB + MHgb). Results
(expressed as means SEM were analyzed by one-way ANOVA and the
Student-Newman-Keuls test. * P < 0.05 vs. eveiy other condition.
Thus, whatever toxicity heme proteins exert on renal epithelial
cells, such damage is inflicted upon cells already compromised in
cellular stores of glutathione. Therefore we studied the potential
cytotoxic effects of heme proteins in intact cells and cells depleted
in their content of reduced glutathione levels.
Human methemoglobin alone failed to exert any toxicity dis-
cernible by the release of chromium: specific cytotoxicity mea-
sured by 51-chromium release was zero. However, the concomi-
tant diminution in glutathione content by CDNB, which itself was
toxic, exposed a marked cytotoxic action of methemoglobin.
Specificity cytotoxicity in renal epithelial cells in which glutathione
was reduced by CDNB more than doubled in the presence of
heme proteins: CDNB versus CDNB + methemoglobin, 19.8
1.3 versus 53.3 1.9%, P < 0.05, N = 4 in each group. Thus a
prooxidant state, induced by the reduction in cellular glutathione
levels, renders heme proteins toxic to the kidney.
Neither CDNB nor methemoglobin increased lipid peroxida-
tion, as measured by TBARS, under the conditions studied (Fig.
4). However, in the combined presence of CDNB and methemo-
globin, a significant increase in TBARS (threefold) occur (Fig. 4).
To determine whether increased lipid peroxidation contributed to
cytotoxicity, we examined the effect of 21-aminosteroids on such
toxicity. As demonstrated in Table 1, these compounds prevented
both the cytotoxicity induced by CDNB and the cytotoxicity
incurred by heme proteins in the setting of diminished glutathione
content. We confirmed that 21-aminosteroids inhibited TBARS
under these conditions in which they are markedly cytoprotective:
TBARS in cells exposed to CDNB and methemoglobin were
strikingly reduced when cells were loaded with 21-aminosteroids
(40 gM), 207.1 6.0 versus 78.1 5.6 pmol/mg protein, P <
0.001, N = 3 in each group.
We tested whether 21-aminosteroids reduced TBARS in a
dose-dependent fashion in cells exposed to CDNB and porcine
hemoglobin (in place of human methemoglobin) and in otherwise
identical conditions to the studies described above (Fig. 5). CDNB
and porcine hemoglobin incurred more than a threefold increase
in TBARS compared to control; significant, dose-dependent
Specific
Condition cytotoxicity
CDNB (N = 8) 34.4 4.9
CDNB + 21 -aminosteroids (N 8) 0.0 0.0
CDNB + methemoglobin (N = 8) 57.8 2.9
CDNB + methemoglobin (N = 8) 0.0 0.Oa
+ 21-amjnosteroids
OpM 1pM 10pM 401.AM
21 -AS
Fig. 5. TBARS in LLC-PKJ cells exposed to media alone (Control) or media
containing CDNB (50 ps'i) and porcine hemoglobin (20 p.M) (CDNB +
Hgb), alone and in the presence of increasing concentrations of 21-amino-
steroids, 1, 10 and 40 1M. Results (expressed as means suM) were
analyzed by one-way ANOVA and the Student-Newman-Keuls test. * P
0.05vs. control; t P < 0.05 vs. CDNB + Hgb; # P < 0.05 vs. CDNB + Hgb
+ 21-AS (1 ELM).
reductions in TBARS were observed in the presence of 21-
aminosteroids, with concentrations as low as 1 M (the lowest
concentration tested) exerting an effect. Cytoprotection provided
by 21-aminosteroids in cells exposed to CDNB and porcine
hemoglobin was also dose-dependent and significant protection
was observed at concentrations of 10 M and 40 .LM (Table 2).
We also confirmed that the vehicle used to dissolve 21-amino-
steroids, DMSO, was without any cytoprotective actions: specific
cytotoxicity of LLC-PK1 cells exposed to CDNB and methemo-
globin was virtually identical to cells exposed to CDNB and
methemoglobin and DMSO (56.9 1.4 vs. 56.8 1.0%, P = NS),
while the specific cytotoxicity in cells exposed to CDNB and
methemoglobin and 21-aminosteroids in DMSO was again 0.0
0,0%.
In complementary studies, we examined the cellular content of
glutathione, as reflected by cellular thiol content, following expo-
sure to heme proteins in the presence and absence of CDNB. As
shown in Figure 6, glutathione levels were reduced to a small but
significant degree following the exposure to methemoglobin
250
200
150
100
50
0
E0.
Cl)
I—
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Specific
Condition cytotoxicity
CDNB Hemoglobin 40.9 0.6
CDNB + Hemoglobin + 21-aminosteroids (0.5 jiM) 31.6 1.7
CDNB Hemoglobin + 21-aminosteroids (1 jiM) 26.0 3.1
CDNB + Hemoglobin + 21-aminosteroids (10 jiM) 0.0 0.0k'
CDNB + Hemoglobin + 21-aminosteroids (40 jiM) 0.0 0.Oa
a P < 0.01 vs. CDNB + hemoglobin alone
alone. As expected, CDNB alone significantly and markedly
decreased glutathione levels. However, the combined presence of
CDNB and heme proteins did not further reduce glutathione
levels. Indeed, while significantly decreased as compared to
control values, the total cellular thiol content in cells exposed to
both CDNB and methemoglobin was higher than values obtained
in cells exposed to CDNB alone. Thus the added toxicity induced
by heme proteins in the presence of CDNB cannot be ascribed to
further reduction in total cellular thiols.
To assess the effect of 21-aminosteroids on the increment in
heme concentrations and/or the net oxidative stress in cells
exposed to methemoglobin in the presence of CDNB, we exam-
ined the expression of heme oxygenase mRNA in these condi-
tions; this gene is promptly expressed in response to increased
heme concentrations and/or oxidative stress [1, 2]. A representa-
tive Northern analysis is shown in Figure 7. As demonstrated,
CDNB alone, and CDNB + methemoglobin in particular, mark-
edly induced heme oxygenase; however, in neither circumstance
did the prior treatment with 21-aminosteroids influence the
expression of this gene. The mean (of duplicates) densitometric
value, factored for the amount of RNA transferred onto the nylon
membrane, for each group is as follows: Control, 15; CDNB, 1800;
CDNB + 21-AS, 2377; CDNB + MetHgb, 7099; CDNB +
MetHgb + 21-AS, 7637. Thus 21-aminosteroids protect without
attenuating the net increment in cellular heme content or the
prooxidative effect so induced.
We also tested the cytotoxic effects of myoglobin (Table 3),
Myoglobin was not toxic to renal epithelial cells at 20 jiM or 80
the lower concentrations of myoglobin were also not toxic
when cellular levels of glutathione were concomitantly reduced.
However fulminant cytotoxicity occurred following exposure to
myoglobin (80 jiM) and CDNB. Such toxicity was totally pre-
vented by 21-aminosteroids.
The heme-protein/CDNB model is hydrogen peroxide-dependent
and 21-aminosteroids protect against cytotoxicily induced by hydro-
gen peroxide in vitro. The protection afforded by 21-aminosteroids
against toxicity induced by CDNB indicates a potent antioxidant
effect of 21-aminosteroids. These effects are particularly relevant
to heme protein-mediated toxicity since an intriguing, and largely
unexplained, finding in in vivo models of heme protein mediated
injury is increased generation of hydrogen peroxide 116]. We
questioned whether our model of heme protein-induced cytotox-
icity is also hydrogen peroxide-dependent and the extent to which
21-aminosteroids can interrupt such hydrogen peroxide-mediated
toxicity.
We first examined the capacity of catalase to protect against
cytotoxicity induced by CDNB and methemoglobin. As demon-
0
Control MHgb CDNB CDNB + MHgb
(N=4) (N=4) (N=4) (N=4)
Fig. 6. Cellular thiol content in LLC-PK, cells exposed to media alone
(Control), or media containing methemoglobin alone (MHgb), CDNB alone
(50 jiM), methemoglobin (20 p.iw) and CDNB (50 jiM) (CDNB + MHgb).
Results (expressed as means 5EM) were analyzed by one-way ANOVA
and the Student-Newman-Keuls test. * P < 0.05 vs. control; t P C 0.05 vs.
MHgb, vs. CDNB + MHgb; # P C 0.05 vs. MHgb.
strated in Table 4, catalase significantly protected against cytotox-
icity resulting from heme protein-induced injury in the setting of
glutathione depletion; catalase did not significantly protect
against cytotoxicity induced by CDNB alone. Thus, the cytoxicity
of heme proteins in the setting of glutathione reduction is
dependent on hydrogen peroxide to an extent that cannot be
explained by reduction in glutathione content alone.
The protection afforded by catalase in this model indicates that
cell injury is hydrogen peroxide-dependent, and thus implies
increased cellular generation of hydrogen peroxide. We consid-
ered whether intracellular heme content, which is markedly
increased following exposure to heme proteins, stimulates cellular
generation of hydrogen peroxide. As demonstrated in Figure 8A,
the exposure of cells to heme for 2.5 hours led to a dose-
dependent increase in fluorescence of cells loaded with the
hydrogen peroxide-sensitive probe, DCF. The mean fluorescence
units obtained with 50 jiM heme was 2425 214, while the
exposure of cells to hydrogen peroxide at concentrations of 50,
100 and 500 j.tM yielded fluorescence values of 294, 448 and 1142,
respectively. We also demonstrated that such fluorescence in cells
exposed to heme is specifically due to hydrogen peroxide since
approximately 40% of such fluoresence was ablated by the
concomitant presence of catalase (Fig. 8B). Thus, heme is a
potent stimulus to generation of hydrogen peroxide in renal
epithelial cells.
To corroborate this novel finding that increased intracellular
heme per se stimulates cellular generation of hydrogen peroxide,
we employed another assay system for the detection of hydrogen
peroxide, aminotriazole-dependent inhibition of catalase. Colon-
metric assays such as the Xylenol Orange assay or Phenol Red
proved unsatisfactory since heme interferes with the speetropho-
tometrie detection of color change. The basis for the aminotria-
sole-inhibition of catalase assay for the detection of hydrogen
peroxide is as follows. Normally, hydrogen peroxide, generated in
the course of cellular metabolism, reacts with catalase to form
Compound I; this intermediate decomposes to yield water and
Table 2. Effect of 21-aminostcroids on cytotoxicity induced by CDNB
(50 jiM) and porcine hemoglobin (20 jiM) (Hgb) after 6 hrs and
measured by 51-chromium release assay (N = 4 in each group)
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Heme oxygenase
mRNA
Control CDNB
CDNB/
CDNB/ CDNB/ MetHgb
21-AS MetHgb 21-AS
28S
18S
Ethidium bromide stained membrane
Table 3. Protective effect of 21-aminosteroids on cytotoxicity induced
by CDNB (50 .tM) and myoglobin (20 or 80 jsM) and measured by
51-chromium release assay
Specific
Condition N cytotoxicity
CDNB 4 25.6 4.9
CDNB + 21-aminosteroids 4 0.0 0.Oa
CDNB + myoglobin (20 gM) 4 26.6 2.9
CDNB + myoglobin (20 jiM) 4 1.2 0.oa
+ 21-aminosteroids
CDNB 4 41.4 1.3
CDNB + 21-aminosteroids 4 0.0 0.Oa
CDNB + myoglobin (80 jtM) 4 73.6 0.6
CDNB + myoglobin (80 jiM) 4 0.3 0.3
-i- 21-aminosteroids
ap < 0.05 vs. corresponding experimental condition without 21-ami-
nosteroids
regenerate catalase. However, following the administration of
aminotriazole, Compound I is irreversibly inactivated and thereby
prevented from regenerating catalase activity. Thus, in the pres-
ence of aminotriazole the extent to which catalase is inhibited
reflects the rate of generation of hydrogen peroxide. Using this
assay we found that heme-treated cells displayed heightened
generation of hydrogen peroxide, since the absolute catalase
activity (5.0 1.0 vs. 8.9 0.7 U/mg protein, P < 0.05, N = 5 in
each group) as well as catalase activity expressed as a % of control
values (50.1 3.1 vs. 68.1 5.5%,P < 0.05,N = 5 in each group)
were reduced in heme-treated LLC-PK1 cells.
Since heme per se stimulates cellular generation of hydrogen
peroxide, and prior studies demonstrate that hydrogen peroxide
Fig. 7. A. The Northern analysis for heme
oxygenase mRNA in LLC-PK1 cells e.sposed to
media alone (Control) or media containing
CDNB (50 j.u) alone (CDNB), CDNB (50 pM)
and 21-aminosteroids (40 pM) (CDNB + 21-AS),
CDNB (50 pM) and methemoglobin (20 pM
(CDNB + MetHgb), CDNB (50 pM) and
methemoglobin (20 pill) and 21-aminosteroids
(40 jiM) (CDNB + MetHbg + 21-AS). B. The
ethidium bromide-stained membrane for 28S
and l8S RNA.
Table 4. Effect of catalase (800 U/mi) on cytotoxicity induced by
CDNB (50 pM) and methemoglobin (20 pM) and measured by
51-chromium release assay
Specific
Condition N cytotoxicity
CDNB 6 29.0 2.4
CDNB + catalase 6 24.0 2.8
CDNB + methemoglobin 6 55.7 2.6
CDNB + methemoglobin
+ catalase
6 32.0 2.8a
P < 0.05 vs. corresponding experimental condition without catalase
can stimulate lipid peroxidation in vitro, we tested whether
21-aminosteroids can protect against cytotoxicity induced by
hydrogen peroxide. As shown in Table 5, at earlier time-points,
that is, at 3 and 4.5 hours of exposure, 21-aminosteroids totally
prevented cytotoxicity induced by hydrogen peroxide, while at six
hours cytotoxicity was reduced by approximately 50% by 21-
aminosteroids. Thus, hydrogen peroxide-dependent cytotoxicity is
inhibited by 21-aminosteroids.
Discussion
We demonstrate that 21-aminosteroids, a novel class of anti-
oxidants, protect against renal injury induced by heme proteins in
vivo and in vitro. Acutely infused, heme proteins reduced GFR
and renal blood flow rates, the latter attended by increased renal
vascular resistances. Such effects were markedly attenuated by
prior treatment with 21-aminosteroids. In a bone fide model of
heme protein-induced nephrotoxicity, the glycerol model (8 ml!
/
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Fig. 8. A. Effect of heme (10 gss and 50 psi) on
DCF-dependent fluorescence in LLC-PK1 cells.
B. catalase-dependent fluorescence in LLC-PK1
cells exposed to heme (50 gM). Results
(expressed as means sENt) were analyzed by
one-way ANOVA and the Student-Newman-
Keuls test. * P C 0.05 vs. control; t P C 0.05
vs. heme (in A, 10 sM; in B, 50 tLM).
Specific
Condition N cytotoxicity
H202 (3 hours) 4 8.7 0.1
H202 (3 hours) + 21-aminosteroids 4 0.0 0.Oa
H202 (4.5 hours) 4 29.3 1.1
H202 (4.5 hours) + 21-aminosteroids 4 0.2 Q,Øa
H202 (6 hours) 4 76.8 0.8
H202 (6 hours) + 21-aminosteroids 4 40.3 37a
kg), 21-aminosteroids protected against renal damage. Comple-
menting these in vivo findings are our in vitro studies in which
concomitant reduction in cellular glutathione levels exposed a
fulminant cytotoxic action of heme proteins. In this in vitro model,
cytotoxicity was markedly attenuated by prior treatment with
21-aminosteroids.
The rationale for studying heme protein-induced renal injury in
the presence of diminished cellular glutathione content rests on
the nature of circumstances in vivo in which renal epithelial cells
are exposed to heme proteins. In addition to exposure to heme
proteins in such disease states, renal epithelial cells are also
subjected to ischemia, the latter provoked by the vasoconstrictive
effects of heme proteins [7]. Ischemia induces multiple adverse
cellular effects including diminution in cellular glutathione levels
[34]. Moreover, in the glycerol model of heme protein-mediated
renal injury, marked reductions in renal content of glutathione
occur [15]. Such reductions in glutathione content are functionally
significant since the administration of glutathione improves renal
function and lessens histologic injury [15], while conversely,
manipulations that exacerbate depletion of kidney glutathione
content worsens structural and functional impairment in this
model [15]. Thus, the exposure of cells to glutathione-depleting
agents such as CDNB, concomitant with exposure to heme
proteins simulates, at least in part, conditions that occur in vivo.
Nonetheless, it should be pointed out that while such toxicity
incurred by heme proteins was dependent on decreased cellular
content of glutathione, the added toxicity imposed by heme
proteins in glutathione-depleted cells cannot be ascribed to
further depletion in glutathione content. Indeed, cells exposed to
the glutathione-depleting agent as well as methemoglobin exhib-
ited a significantly higher content of glutathione as compared to
cells exposed to the glutathione-depleting agent alone. Thus the
toxicity imposed by heme proteins in this setting likely reflects
some additional pathologic event such as damage to lipid domains
rather than depletion of glutathione per se. In support of this are
our findings of markedly increased TBARS in cells exposed to
both CDNB and methemoglobin. In this circumstance 21-ami-
nosteroids proved remarkably protective. We confirmed that
21-aminosteroids reduced TBARS in a dose-dependent manner
exerting such an effect at the lowest concentration tested, that is,
1 MM (Figure 5); 21-aminosteroids also exhibited a dose-depen-
dent cytoprotection with efficacy discernible at concentrations of
10 and 40 MM (Table 2).
Interestingly, 21-aminosteroids were markedly protective
against cell injury induced by CDNB alone, an agent that pro-
voked considerable toxicity but one that did not, at least under the
conditions employed in our study, increase TBARS. CDNB may
exert effects on other cellular thiols in addition to its well-
recognized effect of depleting cellular glutathione content [25].
These findings suggest that 21-aminosteroids may possess protec-
tive actions that are not necessarily dependent on, and may extend
beyond, the inhibition of lipid peroxidation.
In contrast to cytotoxicity induced by CDNB alone, cytotoxicity
induced by the combined application of CDNB and methemoglo-
bin was ameliorated by catalase, findings that bespeak a role for
hydrogen peroxide in cytotoxicity induced by CDNB and methe-
moglobin. Since intracellular levels of heme are expected to
markedly increase in cells exposed to CDNB and methemoglobin,
we considered the possibility that heme per se stimulates cellular
generation of hydrogen peroxide. As attested by two independent
methods, we provide the first demonstration that heme directly
stimulates the cellular generation of hydrogen peroxide in epithe-
hal cells. These observations are particularly relevant to in vivo
models of heme protein-mediated renal injury that display the
curious, and to date unexplained, finding of enhanced generation
of hydrogen peroxide [16]. Such enhanced generation of hydrogen
peroxide is functionally significant since nonezymatic scavengers
of hydrogen peroxide such as pyruvate are protective in this
disease model [21]. In states of heme protein-mediated injury,
heme proteins escape into the urinary space and are endocytosed
by the proximal tubular epithelium. Once within renal epithelial
cells, heme proteins dissociate into the heme prosthetic group and
the globin moiety [35, 36]. Based on our findings, we suggest that
increased amounts of heme in the intracellulat space contributes
to enhanced generation of hydrogen peroxide. Thus, we provide
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Table 5. Protective effect of 21-aminosteroids on cytotoxicity induced
by H202 applied at (1 mM) and measured by 51-chromium release assay
P C 0.05 vs. corresponding experimental condition without 21-ami-
nosteroids
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novel information with regard to heme protein-mediated renal
injury: heme, released from heme proteins, may not only promote,
as is well recognized, the formation of lipid peroxides but such
heme directly stimulates the cellular generation of hydrogen
peroxide. Such increased rates of generation of hydrogen perox-
ide may result from the effects of heme on lipid bilayers. Heme is
markedly lipophilic and, by peroxidating membrane lipid, may
promote membrane leakiness. In an organelle such as the mito-
chondrion, increased membrane permeability may allow the back-
leak of protons, an attendant increase in mitochondrial oxygen
consumption, and along with the latter, increased generation of
reactive oxygen species. It is also possible that the heme prosthetic
group may impair the antioxidant defense mechanisms such that
the scavenging of hydrogen peroxide, generated normally in the
course of oxidative metabolism, may be insufficiently degraded by
these hydrogen peroxide-consuming pathways, thereby leading to
increased net generation of hydrogen peroxide.
Since hydrogen peroxide, generated in excessive amounts,
contributes to damage in vivo models of heme protein-mediated
renal injury, and additionally can provoke lipid peroxides in
tissues [21, 37], we considered whether hydrogen peroxide in-
duced-injury can be attenuated by 21-aminosteroids. As shown in
Table 5, 21-aminosteroids prevented such damage during shorter
exposures to hydrogen peroxide, and markedly reduced such
toxicity at more sustained exposure. Thus, in addition to guarding
against cell injury induced by lipid peroxides, these antioxidants
can protect against injury induced by hydrogen peroxide, an
oxidant that can provoke lipid peroxidation.
That cells "see" increased amounts of heme in the intracellular
compartment under the conditions employed is supported by
several observations. Firstly, heme oxygenase mRNA, a gene
exquisitely sensitive to increments in intracellular levels of free
heme [1, 2], is expressed in cells exposed to methemoglobin alone
and particularly so when exposed to methemoglobin and CDNB
(Fig. 7). Secondly, cells exposed to methemoglobin alone display
a significant, albeit modest (13%), reduction in cellular thiol
content, raising the possibility that heme from methemoglobin
consumes cellular thiols (Fig. 6). Thirdly, the higher thiol content
in cells exposed to CDNB and methemoglobin as compared to
cells exposed to CDNB alone (Fig. 6) may reflect the cellular
effects of increased amounts of free heme. Heme inhibits the
enzyme glutathione S-transferase [38]; this latter enzyme catalyzes
the formation of adducts between CDNB and glutathione, and
thus facilitates depletion of cell thiol content by CDNB [38].
Heme-induced inhibition of this enzyme may thus impede the
capacity of CDNB to consume cellular thiols.
The efficacy and vigor with which 21-aminosteroids protect lipid
bilayers are underscored by the unaltered expression of heme
oxygenase mRNA in cells treated with 21-aminosteroids. Protec-
tion against oxidative stress may be achieved by either safeguard-
ing the vulnerable and critical loci of oxidative attack and/or
attenuating the severity of the oxidative insult [39, 40]. Heme
oxygenase is a protein strongly expressed in tissues such as the
kidney when these tissues are exposed to heme proteins [1, 2, 22].
Such induction of heme oxygenase is protective since it affords the
clearance of heme [22, 40]. Additionally, heme oxygenase mRNA
is up-regulated when the redox balance of cells is shifted to a more
prooxidant state [1, 2]. Induction of heme oxygenase in such
circumstances may provide cytoprotective effects [1, 2]. Expres-
sion of heme oxygenase thus represents an adaptive response
mounted by cells menaced by heme and/or oxidative stress, and
the magnitude of such induction provides a biologic gauge of the
threat that the cell perceives [40]. In this regard, astonishing
cytoprotection to cells treated with both methemoglobin and
CDNB or CDNB alone is conferred by 21-aminosteroids without
any reduction in respective induction of heme oxygenase. The
failure of 21-aminosteroids to mitigate the magnitude of induction
of heme oxygenase implies that 21-aminosteroids do not diminish
the extent to which cellular content of heme is increased or the
extent to which the cellular redox state is rendered prooxidant.
That the cellular oxidative insult persists unabated in 21-amino-
steroids-treated cells whereas cytolysis is prevented emphasizes
the specific and impressive protection that these agents can confer
to lipid bilayers.
In addition to these in vitro effects, 21-aminosteroids protected
against acute and subacute toxicity exerted by heme proteins on
the kidney in vivo. 21-aminosteroids attenuate the impairment in
renal hemodynamics induced by heme proteins, independent of
effects on systemic arterial pressure. These findings raise the
possibility that lipid oxidation, or an effect thereof, is a critical
contributor to the reductions in glomerular filtration rate and
renal blood flow rates. Germane to these findings are the obser-
vations by Badr, Morrow and Roberts and collaborators demon-
strating that, through noncyclooxygenase-dependent mechanisms,
lipid peroxidation yields prostanoids termed F2-isoprostanes.
These prostanoids induce marked and selective reductions in
renal blood flow and glomerular filtration rates without significant
effects on systemic hemodynamics [41, 42]. We speculate that
heme proteins, by virtue of their oxidative effects, may provoke
the generation of such prostanoid species thereby leading to
impairment in renal hemodynamics. Since other mechanisms
besides increased lipid peroxidation may account for the vascular
changes induced in vivo by heme proteins, it would be of interest
to determine in vivo the effect of heme proteins on renal
production of lipid peroxidation and F2-isoprostanes in the pres-
ence and absence of 21-aminosteroids.
Our findings are consistent with prior studies demonstrating
that lazaroids protect iron-loaded endothelial cells against oxidant
damage [43]. Our observations are also consistent with prelimi-
nary findings demonstrating that 21-aminosteroids protect against
hydrogen peroxide-induced renal injury in vitro [44], while vitamin
E-like amines, which inhibits lipid peroxidation, protect against
renal injury in the glycerol model [45]. 21-aminosteroids protect
against lung injury induced by organic peroxides [46], an experi-
mental model markedly exacerbated by heme proteins [47]. In
models of ischemic and traumatic neurologic injury, ones in which
heme proteins may be expected to foster oxidative stress, 21-
aminosteroids confer impressive protection [191.
Based on our findings, we suggest that the following sequence
of events may contribute to the nephrotoxicity of heme proteins:
heme proteins provoke 21-aminosteroids-inhibitible vasoconstric-
tion, the latter possibly through oxidant-driven synthesis of F2-
isoprostanes. Vasoconstriction reduces renal content of glutathi-
one thereby rendering renal epithelial cells vulnerable to the
toxicity of heme proteins, a toxicity that is impressively attenuated
by 21-aminosteroids. Our findings that heme stimulates the cellu-
lar generation of hydrogen peroxide, and that such cytotoxicity is
inhibited by 21-aminosteroids, uncovers a heme-initiated, hydro-
gen peroxide-dependent, amplification pathway for heme protein-
mediated injury. Our findings also raise the possibility that these
Nath et al: 21-aminosteroids and renal injuty 601
compounds may afford a therapeutic approach in minimizing
renal damage that arises as a complication of rhabdomyolysis,
hemolysis and hemoglobin-based red cell substitutes.
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